| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Wesley M Raup-Konsavage, Nurgul Carkaci-Salli, Kelly Greenland, Robert Gearhart, Kent E Vran. Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in vitro. Medical cannabis and cannabinoids. vol 3. issue 2. 2021-10-23. PMID:34676344. |
several studies have found that cannabinoids, particularly delta-9-tetrahydrocannabinol and cannabidiol (cbd), have the ability to reduce cancer cell viability. |
2021-10-23 |
2023-08-13 |
Not clear |
| Joshua D Brown, Amie J Goodi. Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation. Medical cannabis and cannabinoids. vol 4. issue 1. 2021-10-23. PMID:34676351. |
evidence in context: high risk of bias in medical cannabis and cannabinoid clinical trials dictates the need for cautious interpretation. |
2021-10-23 |
2023-08-13 |
Not clear |
| Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. |
medicinal and psychoactive effects of cannabis rely on specific terpenophenolic ligands named cannabinoids. |
2021-10-22 |
2023-08-13 |
Not clear |
| Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. |
results show that cannabinoid oxidocyclase genes originated in the cannabis lineage from within a larger gene expansion in the cannabaceae family. |
2021-10-22 |
2023-08-13 |
Not clear |
| Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. |
localization and divergence of oxidocyclase genes in the cannabis genome revealed two main syntenic blocks, each comprising tandemly repeated cannabinoid oxidocyclase genes. |
2021-10-22 |
2023-08-13 |
Not clear |
| Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. |
although wild populations of cannabis are still unknown, increased sampling of landraces and wild/feral populations across its native geographic range is likely to uncover additional cannabinoid oxidocyclase sequence variants. |
2021-10-22 |
2023-08-13 |
Not clear |
| Waleed Hassan Almalk. A study of abnormal cannabidiols system-mediated cardiovascular protection in disrupted gut/brain axis associated depression. Journal of biochemical and molecular toxicology. 2021-10-22. PMID:34676637. |
the cardiovascular effects of tetrahydrocannabinol (thc) (the key psychotropic credential of cannabis) and endocannabinoids (thc endogenous equivalents which cause type 1 [cb1] and 2 [cb2] cannabinoids) have been extensively examined based on well-documented effects of marijuana smoke on blood pressure (bp) and heart rate (hr). |
2021-10-22 |
2023-08-13 |
Not clear |
| Chia-Shan Wu, Christopher P Jew, Hui-Chen L. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future neurology. vol 6. issue 4. 2021-10-21. PMID:22229018. |
lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. |
2021-10-21 |
2023-08-12 |
human |
| Chia-Shan Wu, Christopher P Jew, Hui-Chen L. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future neurology. vol 6. issue 4. 2021-10-21. PMID:22229018. |
in this article, we examine human longitudinal cohort studies that document the long-term influence of prenatal exposure to cannabis, followed by an overview of the molecular composition of the endocannabinoid system and the temporal and spatial changes in their expression during brain development. |
2021-10-21 |
2023-08-12 |
human |
| Carmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, Nick Clarkson, Clive Pag. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary pharmacology & therapeutics. vol 69. 2021-10-21. PMID:34082108. |
studies with cannabis sativa plant extracts and endogenous agonists of cannabinoid receptors have demonstrated anti-inflammatory, bronchodilator, and antitussive properties in the airways of allergic and non-allergic animals. |
2021-10-21 |
2023-08-13 |
Not clear |
| Carmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, Nick Clarkson, Clive Pag. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary pharmacology & therapeutics. vol 69. 2021-10-21. PMID:34082108. |
however, the potential therapeutic use of cannabis and cannabinoids for the treatment of respiratory diseases has not been widely investigated, in part because of local irritation of airways by needing to smoke the cannabis, poor bioavailability when administered orally due to the lipophilic nature of cannabinoids, and the psychoactive effects of Δ9-tetrahydrocannabinol (Δ9-thc) found in cannabis. |
2021-10-21 |
2023-08-13 |
Not clear |
| Carmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, Nick Clarkson, Clive Pag. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary pharmacology & therapeutics. vol 69. 2021-10-21. PMID:34082108. |
the primary purpose of this study was to investigate the anti-inflammatory effects of two of the non-psychotropic cannabinoids, cannabidiol (cbd) and cannabigerol (cbg) alone and in combination, in a model of pulmonary inflammation induced by bacterial lipopolysaccharide (lps). |
2021-10-21 |
2023-08-13 |
Not clear |
| Gi Liou, Ab El-Remessy, As Ibrahim, Rb Caldwell, Ym Khalifa, A Gunes, Jj Nussbau. Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. Current pharmacogenomics and personalized medicine. vol 7. issue 3. 2021-10-20. PMID:20953236. |
this review is focused on cannabidiol, a non-psychoactive native cannabinoid, as an emerging and novel therapeutic modality based on systematic studies in animal models of inflammatory retinal diseases including diabetic retinopathy - one of the retinal diseases associated with vascular neuroinflammation. |
2021-10-20 |
2023-08-12 |
Not clear |
| Philip R Cohe. Therapeutic and Cosmetic Uses of Cannabis: Cannabinoids for Acne Treatment and Skin -Rejuvenation. Skinmed. vol 19. issue 1. 2021-10-19. PMID:33658112. |
therapeutic and cosmetic uses of cannabis: cannabinoids for acne treatment and skin -rejuvenation. |
2021-10-19 |
2023-08-13 |
Not clear |
| Jessica Rice, Andrea Hildebrand, Rebecca Spain, Angela Senders, Elizabeth Silbermann, Lindsey Wooliscroft, Vijayshree Yadav, Dennis Bourdette, Michelle Camero. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington. Multiple sclerosis and related disorders. vol 55. 2021-10-19. PMID:34332457. |
evidence supports that cannabinoids reduce self-reported spasticity and neuropathic pain in people with ms (pwms), and legal access to cannabis for medical and recreational use continues to rise. |
2021-10-19 |
2023-08-13 |
Not clear |
| Bao Xue, Xia Zhang, Ying Wan. Bench to bedside: Multiple facets of cannabinoid control in epilepsy. Neurochemistry international. vol 141. 2021-10-18. PMID:33159980. |
further in clinic, cannabidiol as an add-on treatment could reduce seizures in patients with treatment-resistant epilepsy, but the underlying mechanisms are still unclear and independent of the endocannabinoid system. |
2021-10-18 |
2023-08-13 |
Not clear |
| Anees Bahj. Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 66. issue 6. 2021-10-18. PMID:33998318. |
response to canadian psychiatric association cannabinoid products position statement: potential for ameliorating cannabis withdrawal. |
2021-10-18 |
2023-08-13 |
Not clear |
| Martyna Hordowicz, Jerzy Jarosz, Małgorzata Czaplińska, Agnieszka Leonhard, Anna Klimkiewic. Polish Physicians' Perspectives on Medical Cannabis Policy and Educational Needs: Results of An Online Survey. Journal of clinical medicine. vol 10. issue 19. 2021-10-16. PMID:34640561. |
furthermore, 71.7% believed that medicines containing cannabinoids and 52.0% that herbal cannabis should be reimbursed (3). |
2021-10-16 |
2023-08-13 |
human |
| Sirichai Chayasirisobho. Mechanisms of Action and Pharmacokinetics of Cannabis. The Permanente journal. vol 25. 2021-10-15. PMID:33635755. |
at least 100 cannabis species are compounds known as cannabinoids, a molecule with a 21-carbon terpenophenolic skeleton. |
2021-10-15 |
2023-08-13 |
Not clear |
| Sirichai Chayasirisobho. Mechanisms of Action and Pharmacokinetics of Cannabis. The Permanente journal. vol 25. 2021-10-15. PMID:33635755. |
cannabinoids produce more than 100 naturally occurring chemicals, the most abundant of which are Δ-9-tetrahydrocannabinol (thc), cannabidiol (cbd), terpenes, and flavonoids. |
2021-10-15 |
2023-08-13 |
Not clear |